π
|
Telaprevir for previously untreated chronic hepatitis C virus infection.
24 auth.
I. Jacobson,
J. Mchutchison,
G. Dusheiko,
A. Bisceglie,
K. Reddy,
N. Bzowej,
P. Marcellin,
A. Muir,
P. Ferenci,
R. Flisiak,
...
J. George,
M. Rizzetto,
D. Shouval,
R. SolΓ‘,
R. Terg,
E. Yoshida,
N. Adda,
L. Bengtsson,
A. Sankoh,
Tara L. Kieffer,
S. George,
R. Kauffman,
S. Zeuzem,
V. Phar
|
11 |
2011 |
11 π
|
π
|
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
9 auth.
A. Regev,
M. Berho,
L. Jeffers,
C. Milikowski,
E. Molina,
N. Pyrsopoulos,
...
Zheng Feng,
K. Reddy,
E. Schiff
|
11 |
2002 |
11 π
|
π
|
Boceprevir for untreated chronic HCV genotype 1 infection.
15 auth.
F. Poordad,
J. McCone,
B. Bacon,
S. Bruno,
Michael P. Manns,
M. Sulkowski,
I. Jacobson,
K. Reddy,
Z. Goodman,
N. Boparai,
...
M. Dinubile,
V. Sniukiene,
C. Brass,
J. Albrecht,
J. Bronowicki
|
10 |
2011 |
10 π
|
π
|
Sofosbuvir for previously untreated chronic hepatitis C infection.
24 auth.
E. Lawitz,
A. Mangia,
D. Wyles,
M. RodriΜguez-Torres,
T. Hassanein,
S. Gordon,
M. Schultz,
Mitchell N. Davis,
Z. Kayali,
K. Reddy,
...
I. Jacobson,
K. Kowdley,
L. Nyberg,
G. Subramanian,
R. Hyland,
S. Arterburn,
D. Jiang,
J. McNally,
D. Brainard,
W. Symonds,
J. Mchutchison,
A. Sheikh,
Z. Younossi,
E. Gane
|
10 |
2013 |
10 π
|
π
|
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
25 auth.
N. Afdhal,
K. Reddy,
D. Nelson,
E. Lawitz,
S. Gordon,
E. Schiff,
R. Nahass,
R. Ghalib,
N. Gitlin,
R. Herring,
J. Lalezari,
Z. Younes,
P. Pockros,
A. D. Di Bisceglie,
Sanjeev Arora,
...
G. Subramanian,
Yanni Zhu,
H. DvoryβSobol,
Jenny C. Yang,
P. Pang,
W. Symonds,
J. Mchutchison,
A. Muir,
M. Sulkowski,
P. Kwo
|
10 |
2014 |
10 π
|
π
|
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
25 auth.
K. Kowdley,
S. Gordon,
K. Reddy,
L. Rossaro,
D. Bernstein,
E. Lawitz,
M. Shiffman,
E. Schiff,
R. Ghalib,
M. Ryan,
V. Rustgi,
M. Chojkier,
R. Herring,
A. D. Di Bisceglie,
P. Pockros,
...
G. Subramanian,
D. An,
E. Svarovskaia,
R. Hyland,
P. Pang,
W. Symonds,
J. Mchutchison,
A. Muir,
D. Pound,
M. Fried
|
10 |
2014 |
10 π
|
π
|
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
51 auth.
M. Charlton,
G. Everson,
S. Flamm,
Princy N. Kumar,
C. Landis,
Robert S. Brown,
M. Fried,
N. Terrault,
J. OβLeary,
H. Vargas,
A. Kuo,
E. Schiff,
M. Sulkowski,
R. Gilroy,
K. Watt,
...
K. Brown,
P. Kwo,
S. Pungpapong,
K. Korenblat,
A. Muir,
L. Teperman,
R. Fontana,
J. Denning,
S. Arterburn,
H. DvoryβSobol,
T. Brandt-Sarif,
P. Pang,
J. Mchutchison,
K. Reddy,
N. Afdhal,
M. Fried,
K. Kowdley,
N. Terrault,
S. Flamm,
J. Lake,
G. Everson,
M. Sulkowski,
M. Curry,
R. Reddy,
H. Vargas,
A. Muir,
A. Zaman,
R. Fontana,
J. OβLeary,
O. Shaikh,
K. Korenblat,
R. Stravitz,
K. Watt,
N. Menon,
J. Bredfeldt,
Carlos RomeroβMarrero
|
9 |
2015 |
9 π
|
π
|
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
22 auth.
Michael P. Curry,
J. OβLeary,
N. Bzowej,
A. Muir,
K. Korenblat,
J. Fenkel,
K. Reddy,
E. Lawitz,
S. Flamm,
T. Schiano,
...
L. Teperman,
R. Fontana,
EugeneR. Schiff,
M. Fried,
B. Doehle,
D. An,
J. McNally,
A. Osinusi,
D. Brainard,
J. Mchutchison,
Robert S. Brown,
Michael Charlton
|
9 |
2015 |
9 π
|
π
|
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
80 auth.
N. Chalasani,
H. Bonkovsky,
R. Fontana,
William M. Lee,
A. Stolz,
J. Talwalkar,
K. Reddy,
P. Watkins,
VΓctor M. Navarro,
Huiman Barnhart,
Jiezhun Gu,
J. Serrano,
J. Ahmad,
N. Bach,
M. Bansal,
...
H. Barnhart,
K. Beavers,
H. Bonkovsky,
F. Calvo,
Charissa Y. Chang,
H. Conjeevaram,
Gregory E. Conner,
J. Darling,
Ynto S. de Boer,
D. Dieterich,
F. DiPaola,
F. Durazo,
James E. (Jay) Everhart,
R. Fontana,
M. Ghabril,
D. Goldstein,
Vani Gopalreddy,
P. Grewal,
P. Hayashi,
J. Hoofnagle,
N. Kaplowitz,
S. Liangpunsakul,
Steven M. Lichtman,
Lawrence U. Liu,
V. Navarro,
J. Odin,
S. Rossi,
M. Russo,
T. Schiano,
J. Serrano,
A. Sherker,
R. Vuppalanchi,
P. Watkins,
S. Zacks,
Amanda Balasco,
Kristin Chesney,
Audrey Corne,
Sherrie Cummings,
G. Groseclose,
Alex Hammett,
J. Hooker,
Varun Kesar,
Sophana Mao,
Kenari Marks,
R. McFadden,
Yolanda Melgoza,
Sherif Mikhail,
S. Milstein,
Wendy Morlan,
V. Peacock,
Nidia Rosado,
T. Russell,
Maricruz Vega,
M. Verma,
Patricia Walker,
R. Yalamanchili,
Michelle McClanahan-Crowder,
K. Galan,
Jiezhun (Sherry) Gu,
T. Chau,
K. Ragavan,
H. Rostami,
Carmel Puglisi-Scharenbroich,
Rebecca J. Torrance,
Rebekah Van Raaphorst
|
9 |
2015 |
9 π
|
π
|
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
16 auth.
J. Marrero,
Ziding Feng,
Yinghui Wang,
M. Nguyen,
A. Befeler,
L. Roberts,
K. Reddy,
D. Harnois,
J. Llovet,
D. Normolle,
...
Jackie Dalhgren,
D. Chia,
A. Lok,
P. Wagner,
S. Srivastava,
M. Schwartz
|
9 |
2009 |
9 π
|
π
|
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
33 auth.
H. Ford,
M. Bourliere,
S. Gordon,
S. Flamm,
C. Cooper,
A. Ramji,
M. Tong,
N. Ravendhran,
J. Vierling,
T. Tran,
S. Pianko,
M. Bansal,
V. Ledinghen,
R. Hyland,
L. Stamm,
...
H. DvoryβSobol,
E. Svarovskaia,
Jie Zhang,
K. C. Huang,
G. Subramanian,
D. Brainard,
J. Mchutchison,
E. Verna,
P. Buggisch,
C. Landis,
Z. Younes,
M. Curry,
S. Strasser,
E. Schiff,
K. Reddy,
M. Manns,
K. Kowdley,
S. Zeuzem
|
9 |
2017 |
9 π
|
π
|
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
31 auth.
R. Chung,
M. Ghany,
A. Kim,
K. Marks,
S. Naggie,
H. Vargas,
A. Aronsohn,
D. Bhattacharya,
Tina Broder,
Oluwaseun O Falade-Nwulia,
R. Fontana,
S. Gordon,
T. Heller,
S. Holmberg,
R. Jhaveri,
...
M. Jonas,
J. Kiser,
B. Linas,
V. Lo Re,
T. Morgan,
R. Nahass,
M. Peters,
K. Reddy,
A. Reynolds,
John D. Scott,
Gloria Searson,
T. Swan,
N. Terrault,
S. Trooskin,
J. Wong,
K. Workowski
|
9 |
2018 |
9 π
|
π
|
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon Ξ±β2a (40 kd)/ribavirin therapy
9 auth.
D. Jensen,
T. Morgan,
P. Marcellin,
P. Pockros,
K. Reddy,
S. Hadziyannis,
...
P. Ferenci,
A. Ackrill,
B. Willems
|
9 |
2006 |
9 π
|
π¦
|
American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
K. Reddy,
K. Beavers,
S. Hammond,
Joseph K. Lim,
Y. Falck-Ytter
|
9 |
2015 |
9 π¦
|